These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 14520472)

  • 21. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
    Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NS-398 treatment after trauma modifies NF-kappaB activation and improves survival.
    Mack Strong VE; Mackrell PJ; Concannon EM; Mestre JR; Smyth GP; Schaefer PA; Stapleton PP; Daly JM
    J Surg Res; 2001 Jun; 98(1):40-6. PubMed ID: 11368536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
    Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydrotestosterone (DHT) modulates the ability of NSAIDs to induce apoptosis of prostate cancer cells.
    Andrews P; Krygier S; Djakiew D
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):179-86. PubMed ID: 11935209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
    J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.
    Abiru S; Nakao K; Ichikawa T; Migita K; Shigeno M; Sakamoto M; Ishikawa H; Hamasaki K; Nakata K; Eguchi K
    Hepatology; 2002 May; 35(5):1117-24. PubMed ID: 11981761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways.
    Liu W; Reinmuth N; Stoeltzing O; Parikh AA; Tellez C; Williams S; Jung YD; Fan F; Takeda A; Akagi M; Bar-Eli M; Gallick GE; Ellis LM
    Cancer Res; 2003 Jul; 63(13):3632-6. PubMed ID: 12839952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells.
    Levitt RJ; Pollak M
    Cancer Res; 2002 Dec; 62(24):7372-6. PubMed ID: 12499282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain.
    Madrigal JL; Moro MA; Lizasoain I; Lorenzo P; Fernández AP; Rodrigo J; Boscá L; Leza JC
    Neuropsychopharmacology; 2003 Sep; 28(9):1579-88. PubMed ID: 12784118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
    Totzke G; Schulze-Osthoff K; Jänicke RU
    Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells.
    Lim JW; Kim H; Kim KH
    Lab Invest; 2001 Mar; 81(3):349-60. PubMed ID: 11310828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COX-2 specific inhibitor, NS-398, increases macrophage migration inhibitory factor expression and induces neuroendocrine differentiation in C4-2b prostate cancer cells.
    Meyer-Siegler K
    Mol Med; 2001 Dec; 7(12):850-60. PubMed ID: 11876163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60.
    Han SS; Kim K; Hahm ER; Lee SJ; Surh YJ; Park HK; Kim WS; Jung CW; Lee MH; Park K; Yang JH; Yoon SS; Riordan NH; Riordan HD; Kimler BF; Park CH; Lee JH; Park S
    J Cell Biochem; 2004 Oct; 93(2):257-70. PubMed ID: 15368354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells.
    Efsen E; Bonacchi A; Pastacaldi S; Valente AJ; Wenzel UO; Tosti-Guerra C; Pinzani M; Laffi G; Abboud HE; Gentilini P; Marra F
    Hepatology; 2001 Mar; 33(3):713-21. PubMed ID: 11230753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.
    Zhang H; Ye Y; Bai Z; Wang S
    Dig Dis Sci; 2008 Aug; 53(8):2195-203. PubMed ID: 18320325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COX-2 regulates p53 activity and inhibits DNA damage-induced apoptosis.
    Choi EM; Heo JI; Oh JY; Kim YM; Ha KS; Kim JI; Han JA
    Biochem Biophys Res Commun; 2005 Mar; 328(4):1107-12. PubMed ID: 15707991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target.
    Kim SH; Song SH; Kim SG; Chun KS; Lim SY; Na HK; Kim JW; Surh YJ; Bang YJ; Song YS
    J Cancer Res Clin Oncol; 2004 Sep; 130(9):551-60. PubMed ID: 15197583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences.
    Benitah SA; Valerón PF; Lacal JC
    Mol Biol Cell; 2003 Jul; 14(7):3041-54. PubMed ID: 12857884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.